COOL - PolarityTE, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

PolarityTE, Inc.

615 Arapeen Drive
Suite 102
Salt Lake City, UT 84108
United States

Full Time Employees33

Key Executives

NameTitlePayExercisedYear Born
Dr. Denver M. LoughChairman, CEO & Chief Scientific OfficerN/AN/A1981
Mr. Paul Elliot MannChief Financial OfficerN/AN/AN/A
Dr. Edward Winslow SwansonChief Operating OfficerN/AN/A1985
Mr. Rich HaerleVP of Investor Relations & StrategyN/AN/AN/A
Mr. Cameron J. Hoyler J.D.Gen. CounselN/AN/A1984
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


PolarityTE, Inc. operates as commercial-stage biotechnology and regenerative biomaterials company in the United States. The company focuses on discovering, designing and developing a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences. Its PolarityTE platform would be able to provide transform tissue regeneration, including potential regeneration of multiple tissue substrates, such as skin, bone, muscle, fat, cartilage, nerves, and blood vessels, as well as neural elements, solid and hollow organ composite tissue systems. The company is headquartered in Salt Lake City, Utah.

Corporate Governance

PolarityTE, Inc.’s ISS Governance QualityScore as of September 1, 2018 is 10. The pillar scores are Audit: 2; Board: 10; Shareholder Rights: 9; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.